Randomized controlled trials in oncology can make or break an investigational drug, with both patient lives and pharmaceutical company profits at stake. These trials typically pit two options against ...
Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer A key but often overlooked question in oncology clinical ...
Long-term results from the RAISE-XT open-label extension, presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting, demonstrated sustained improvements in ...
Background: Primary care physicians, who manage the care of most children with asthma, often do not optimally assess disease control, prescribe asthma controller medications, or provide family asthma ...
1don MSN
A first-of-its-kind clinical trial bringing life-changing results to those at risk for Alzheimer's
A first-of-its-kind clinical trial is impacting the ways in which the public approaches brain health. U.S. POINTER is a two-year Alzheimer's Association-funded study that showed healthy behaviors have ...
Vitiligo is a chronic autoimmune disease that causes skin depigmentation. A cream formulation of ruxolitinib (an inhibitor of Janus kinase 1 and 2) resulted in repigmentation in a phase 2 trial ...
Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback